Insulet Corp. buy BiotechBee
Start price
08.09.24
/
70%
€196.45
Target price
31.03.27
€230.00
Performance (%)
29.75%
End price
14.12.24
€254.90
Summary
This prediction ended on 14.12.24 with a price of €254.90. The prediction had a final performance of 29.75%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insulet Corp. | -2.884% | -2.884% | -2.769% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
According to BiotechBee what are the pros and cons of Insulet Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Insulet Corp. diskutieren
Buy mit Kursziel 230,0
In the thread Trading Insulet Corp.
Buy beendet

